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An unintended consequence of the 
current focus on the control of HIV/
AIDS, tuberculosis and malaria has 
been a relative neglect of other infec-
tious diseases, such as pneumonia and 
diarrhoea, which still kill many children 
in the developing world.1 Why has the 
control of pneumonia in young chil-
dren been so neglected? Reasons that 
have been suggested include the nature 
of the target group (children in deprived 
communities), the multiple etiolo-
gies of pneumonia, lack of agreement 
among experts on the most appropriate 
intervention strategies and incorpora-
tion of case management of pneumo-
nia into the Integrated Management of 
Childhood Illnesses (IMCI) strategy, 
which has reduced the disease’s visibility.
Over the past few years, several 
attempts have been made to raise the 
profile of childhood pneumonia as a 
public health priority2 but much more 
needs to be done. A recent step forward 
has been the establishment of the 
Global Action Plan for the Prevention 
and Control of Pneumonia (GAPP), 
which to date has held two formal 
meetings (March 2007 and February 
2008), several informal discussions, and 
developed a draft action plan. This issue 
of the Bulletin contains a series of pa-
pers commissioned by GAPP, together 
with some other relevant papers.
The GAPP initiative is helping to 
advance the case for control of child-
hood pneumonia as a public health 
emergency; however, an enhanced, 
high-level, sustained advocacy campaign 
is needed if pneumonia in children is 
to receive the attention that it deserves 
from those who guide and fund inter-
national health. A successful advocacy 
programme requires a clear definition 
of the problem, identification of effec-
tive interventions to deal with it, a plan 
for implementing these interventions, 
and an assessment of their likely costs 
and economic benefits. Until recently, 
there was insufficient information to 
mount such a campaign for childhood 
pneumonia, but a great deal of progress 
in this direction has recently been made, 
as evidenced in the papers in this issue 
of the Bulletin.
As reported by Rudan et al.,3 there 
are now reasonably accurate estimates of 
the annual number of episodes of pneu-
monia among children less than 5 years 
old (ca. 150 million) and of the annual 
number of pneumonia deaths (ca. 2 
million), and two groups of effective in-
terventions have been identified – vacci-
nation and case management. Excellent 
progress has been made recently in 
increasing coverage with measles vac-
cination,4 and Madhi et al.5 report that 
there is now solid evidence to support 
widespread introduction of Haemophilus 
influenzae type b and pneumococ-
cal conjugate vaccines in developing 
countries. These vaccines are safe; and 
DeStefano et al.6 report that the only 
possibly significant side-effect associated 
with pneumococcal conjugate vaccines 
has been an increase in the incidence 
of reactive airway disease shortly after 
vaccination. Other potentially effective 
ways of preventing pneumonia in young 
children include the promotion of 
exclusive breastfeeding during the first 
few months of life, zinc supplementa-
tion (Roth et al.)7 and a reduction in 
indoor air pollution (Dherani et al.).8 
However, more research is needed on 
how the latter two interventions could 
be implemented most effectively before 
national scale-up can be recommended.
None of these preventive mea-
sures is likely to completely prevent 
childhood pneumonia so there is still a 
need for an effective case-management 
strategy. Treatment with antibiotics in 
the community reduces mortality and 
morbidity from pneumonia9 but, as re-
ported by Marsh et al.10 this approach 
has not been implemented widely 
because of concerns over the use of 
antibiotics by relatively untrained 
staff. To ensure that every child with 
severe pneumonia has rapid access to 
treatment with an effective antibiotic, 
treatment in the community by work-
ers with limited training is necessary 
in many developing country situations 
(Källander et al.)11 and is essential in 
ensuring equity in access to treatment 
(Mulholland et al.).12 Community 
management programmes can be scaled 
up effectively, as reported for Nepal by 
Dawson et al.13  Community health 
workers are likely to be most effective in 
rural areas with scattered populations. 
In many urban areas in the develop-
ing world, treatment for pneumonia is 
frequently provided outside the formal 
health sector by practitioners with vari-
ous levels of training. More could be 
done to improve the quality of the care 
that they provide, for example by train-
ing and franchising shop keepers. Care 
of children with pneumonia in health 
facilities also needs to be improved 
(Graham et al.)14 and requires the avail-
ability of oxygen (Enarson et al.).15
A strong and competitive case will 
be needed to persuade the major inter-
national donors to invest in the control 
of pneumonia in children at country 
and global levels. Drawing this up is 
now an urgent priority and will require 
a substantial amount of work by a 
dedicated team of qualified experts who 
will need appropriate financial support. 
The papers presented in this issue of the 
Bulletin provide a good basis for start-
ing this process.  ■
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